Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological Studies.

MLA

Saklatvala, Jake R., et al. “Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological Studies.” The Journal of Investigative Dermatology, vol. 143, no. 8, Aug. 2023, p. 1598. EBSCOhost, https://doi.org/10.1016/j.jid.2023.02.010.

APA

Saklatvala, J. R., Hanscombe, K. B., Mahil, S. K., Tsoi, L. C., Elder, J. T., Barker, J. N., Simpson, M. A., Smith, C. H., & Dand, N. (2023). Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological Studies. The Journal of Investigative Dermatology, 143(8), 1598. https://doi.org/10.1016/j.jid.2023.02.010

Chicago

Saklatvala, Jake R, Ken B Hanscombe, Satveer K Mahil, Lam C Tsoi, James T Elder, Jonathan N Barker, Michael A Simpson, Catherine H Smith, and Nick Dand. 2023. “Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological Studies.” The Journal of Investigative Dermatology 143 (8): 1598. doi:10.1016/j.jid.2023.02.010.